Expression of human leukocyte antigens class I and class II on cultured biliary epithelial cells after cytomegalovirus infection

Tissue Antigens

Volumn 49, Issue 6, 1997, Pages 640-643

  Scholz, M ^a   Cinatl, J ^a   Blaheta, R A ^a   Kornhuber, B ^a   Markus, B H ^a   Doerr, H W ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Cytomegalovirus; HLA

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ARTICLE; CELL CULTURE; CYTOMEGALOVIRUS INFECTION; EPITHELIUM CELL; PRIORITY JOURNAL;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0030920643     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02813.x     Document Type: Article

References (34)

1. Donaldson PT, Alexander GJM, O'Grady JO et al. Evidence for an immune response to HLA class I antigens in the vanishing bile duct syndrome after liver transplantation. Lancet 1987: I,2: 945-8.
2. O'Grady JO, Alexander GJ, Sutherland SH et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation. Lancet 1988: 2: 302 5.
3. Bedlow AJ, Donaldson PT, Mc Farlane BM, Lombard M, Williams R. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis. J Clin Lab Immunol 1989: 30: 103-109.
4. LaRusso NF, Wiesner R, Ludwig J, Mac Carthy RL. Primary sclerosing cholangitis. N Engl J Med 1984: 310: 899-903.
5. Lindor KD, Wiesner R, LaRusso NF, Homburger HA. Enhanced autoreactivity of T lymphocytes in primary sclerosing cholangitis. Hepatology 1987: 7: 884-88.
6. Vierling JM, Fennel RH. Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts. Histopathology 1985: 5: 1076-82.
7. Demetris AJ, Lasky S, Van Thiel DH, Starzl TE, Whiteside T. Induction of DR/Ia antigens in human liver allografts. Transplantation 1985: 40: 504-9.
8. Markus BH, Demetris AJ, Fung JJ et al. Allospecificity of liver allograft derived lymphocytes and correlation with clinicopathological findings. Transplant Proc 1988: 20: 219-22.
9. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of HLA-A, B, C, antigens in normal human organs. Transplantation 1984: 38: 287-92.
10. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of MHC class II antigens in normal human organs. Transplantation 1984: 38: 293-8.
11. Lautenschlager I, Taskinen E, Ikinen K, Lehto VP, Virtanen I, Häyry P. Distribution of the major histocompatibility complex antigens on different components of human liver. Cell Immunol 1984: 85: 191-200.
12. Steinhoff G, Wonigeit K, Pichlmayr R. Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation. Transplantation 1988: 45: 394-401.
13. Takacs L, Szende B, Monostroi E et al. Expression of HLA-DR antigens on bile duct cells of rejected liver transplants. Lancet 1983: 2: 1500-5.
14. Demetris AJ, Markus BH, Saidman S et al. Establishment of primary cultures of human biliary epithelium and induction of class II major histocompatibility complex antigens by gamma interferon. Transplant Proc 1988: 20(suppl 1): 728-30.
15. Auth MKH, Keitzer R, Scholz M et al. Establishment and immunological characterization of cultured human gallbladder epithelial cells. Hepatology 1993: 18: 546-55.
16. Scholz M, Keitzer RA, Blaheta RA et al. Immunological properties of human gallbladder-derived epithelial cells: Flow cytometric analysis of human leukocyte antigens and adhesion molecule ICAM-1. Tissue Antigens 1993: 42: 539-43.
17. Sundstrom JB, Ansari AA. Comparative study of the role of professional versus semiprofessional or nonprofessional antigen presenting cells in the rejection of vascularized organ allografts. Transplant Immunol 1995: 3: 273-89.
18. Manez, R, White LT, Linden P et al. Influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993: 55: 1067-71.
19. Ten-Napel HH, Houthoff HJ, The TH. Cytomegalovirus hepatitis in normal and immune compromised hosts. Liver 1984: 4: 184-94.
20. Keh WC, Gerber MA. In situ hybridization for cytomegalovirus DNA in AIDS patients. Am J Pathol 1988: 131: 490-6.
21. Scholz, M, Hamann A, Blaheta RA et al. Cytomegalovirus- and interferon-related effects on human endothelial cells: cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma. Hum Immunol 1992: 35:230-9.
22. Radsak, K, Fuhrmann R, Franke RP et al. Induction by sodium butyrate of cytomegalovirus replication in human endothelial cells. Arch Virol 1989: 107: 151-8.
23. Hosenpud JD, Chou S, Wagner CR. Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Transplantation 1991: 52: 896-903.
24. Von Willebrand E, Petterson E, Ahonen J, Häyry P. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 1986: 42: 364-7.
25. Van Dorp WT, Jonges E, Bruggeman CA, Daha MR, Van Es LA, Van der Woude FJ. Direct induction of MHC class I, but not class II expression on endothelial cells by cytomegalovirus infection. Transplantation 1989: 48: 469-72.
26. Browne H, Smith G, Beck S, Minson T. A complex between the MHC class I homologue encoded by human cytomegalovirus and beta-2-microglobulin. Nature 1990: 347: 770.
27. Beersma MFC, Bijlmakers MJE, Ploegh HL. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J Immunol 1993: 151: 4455-64.
28. Ustinov J, Loginov R, Bruggeman C, van der Meide P, Häyry P, Lautenschlager I. Cytomegalovirus induces class II expression in rat heart endothelial cells. J Heart Lung Transplant 1993: 12: 644-51.
29. Ng-Bautista CL, Sedmak DD. Cytomegalovirus infection is associated with absence of alveolar epithelial cell HLA class II antigen expression. J Infect Dis 1995: 171: 39-44.
30. Scholz M, Blaheta RA, Cinatl J, Encke A, Doerr HW, Markus BH. Lymphocytes induce enhanced expression of HLA class I antigens on cytomegalovirus-infected syngeneic human endothelial cells. Hum Immunol 1995: 44: 136-44.
31. Waldman WJ, Adams PW, Orosz CG, Sedmak DD. T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation 1992: 54: 887-96.
32. Adams PW, Lee H-S, Ferguson RM, Orosz CG. Alloantigenicity of human endothelial cells. II. Analysis of interleukin 2 production and proliferation by T cells after contact with allogeneic endothelia. Transplantation 1994: 57: 115-22.
33. + T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing class I MHC and intercellular adhesion molecule-1 expression. J Immunol 1990: 145: 1088.
34. Scholz M, Cinatl J, Groβ V et al. Impact of oxidative stress on human cytomegalovirus replication and on cytokine-mediated stimulation of endothelial cells. Transplantation 1996: 61: 1763-70.